BioThrax

BIOLOGICAL7 trials

Sponsors

Emergent BioSolutions, Altimmune, Inc., Biomedical Advanced Research and Development Authority

Conditions

AnthraxBacillus Anthracis (Anthrax) InfectionHealthy Volunteers

Phase 1

Safety, Tolerability and Immunogenicity Study of AV7909 Anthrax Vaccine in Healthy Adults

CompletedNCT01263691

Emergent BioSolutionsBacillus Anthracis (Anthrax) Infection

Start: 2010-12-31End: 2012-06-30Updated: 2024-03-18

NasoShield Study of Safety and Immunogenicity

CompletedNCT03352466

Altimmune, Inc.Healthy Volunteers

Start: 2018-01-18End: 2019-05-13Updated: 2025-06-24

Phase 2

Ciprofloxacin BioThrax Co-Administration Study

CompletedNCT01753115

Emergent BioSolutionsAnthrax

Start: 2012-12-31End: 2013-08-31Updated: 2025-06-15

A Phase 2 Safety and Immunogenicity Study for an Anthrax Vaccine Using 3 Schedules and Two Dose Levels

CompletedNCT01770743

Emergent BioSolutionsAnthrax

Start: 2013-01-31End: 2014-12-31Updated: 2024-03-18

BARDA Securing Anthrax Immunity For the Elderly

CompletedNCT03518125

Biomedical Advanced Research and Development AuthorityAnthrax

Start: 2018-05-09End: 2019-12-09Updated: 2020-07-21

Phase 3

Immunogenicity and Safety Study of a Three-Dose BioThrax® Regimen for Post-Exposure Prophylaxis in Healthy Adults

CompletedNCT01491607

Emergent BioSolutionsAnthrax

Start: 2011-11-30End: 2012-05-31Updated: 2024-04-09

VELOCITY: An Anthrax Vaccine Clinical Study

CompletedNCT03877926

Emergent BioSolutionsAnthrax

Start: 2019-03-11End: 2020-08-06Updated: 2024-03-18

Related Papers

Immunogenicity, safety, and lot consistency of the anthrax vaccine adsorbed, adjuvanted for post-exposure prophylaxis of anthrax in healthy adults: A phase 3, randomized, double-blind trial.

2025-12-15

368. A Phase 3, Randomized, Double-blind, Parallel-group Trial to Evaluate the Immunogenicity and Safety of AV7909 for Post-exposure Prophylaxis of Anthrax in Healthy Adults

Open Forum Infectious Diseases2023-11-27

Evaluation of BioThrax® and AV7909 anthrax vaccines in adults 66 years of age or older

Vaccine2020-10-2813 citations